Total planned funding: $222,356,289
Allocations
Countries/Regions
| Ukraine | $222,356,289 |
Organizational Types
| Unknown | $59,970,995 |
| NGO | $47,855,209 |
| Private Contractor | $40,517,394 |
| Own Agency | $28,590,620 |
| Multi-lateral Agency | $18,451,607 |
| University | $11,727,000 |
| Implementing Agency | $6,925,040 |
| Other USG Agency | $6,468,424 |
| Host Country Government Agency | $1,850,000 |
Program Areas
| Governance and Systems | $96,208,584 |
| Treatment | $37,373,975 |
| Prevention | $27,209,008 |
| Testing | $22,870,418 |
| Management and Operations | $20,312,075 |
| Care | $18,382,229 |
Budget Codes
| OHSS: Health Systems Strengthening | $54,562,036 |
| HVSI: Strategic Information | $24,899,559 |
| HTXS: Treatment: Adult Treatment | $24,809,980 |
| HVCT: Testing: HIV Testing and Counseling | $22,870,418 |
| HVMS: Management and Operations | $20,312,075 |
| HLAB: Laboratory Infrastructure | $16,746,989 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $14,207,846 |
| HTXD: Treatment: ARV Drugs | $12,563,995 |
| HVTB: Care: TB/HIV | $10,387,809 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $8,167,222 |
| HBHC: Care: Adult Care and Support | $4,776,498 |
| HMBL: Biomedical Prevention: Blood Safety | $4,123,493 |
| HKID: Care: Orphans and Vulnerable Children | $3,217,922 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
| HMIN: Biomedical Prevention: Injection Safety | $250,000 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $167,090 |
| PDCS: Care: Pediatric Care and Support | $0 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
| PDTX: Treatment: Pediatric Treatment | $0 |
Top Partner Programs
Not Available:
$56,200,995
Countries/Regions
USG Aggregated Agencies:
$21,821,297
Countries/Regions
Chemonics International:
$21,792,383
Countries/Regions
Pact, Inc.:
$14,545,315
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions